These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11320386)

  • 1. DNA content as a prognostic marker in patients with oral leukoplakia.
    Sudbø J; Kildal W; Risberg B; Koppang HS; Danielsen HE; Reith A
    N Engl J Med; 2001 Apr; 344(17):1270-8. PubMed ID: 11320386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of oral precancerous lesions].
    Sudbø J; Warloe T; Aamdal S; Reith A; Bryne M
    Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3066-71. PubMed ID: 11757442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of resection and aneuploidy on mortality in oral leukoplakia.
    Sudbø J; Lippman SM; Lee JJ; Mao L; Kildal W; Sudbø A; Sagen S; Bryne M; El-Naggar A; Risberg B; Evensen JF; Reith A
    N Engl J Med; 2004 Apr; 350(14):1405-13. PubMed ID: 15070790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia.
    Sudbø J; Bryne M; Johannessen AC; Kildal W; Danielsen HE; Reith A
    J Pathol; 2001 Jul; 194(3):303-10. PubMed ID: 11439362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
    Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
    Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers of the risk of oral cancer.
    Lippman SM; Hong WK
    N Engl J Med; 2001 Apr; 344(17):1323-6. PubMed ID: 11320393
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of DNA ploidy status in patients with oral leukoplakia.
    Bremmer JF; Brakenhoff RH; Broeckaert MA; Beliën JA; Leemans CR; Bloemena E; van der Waal I; Braakhuis BJ
    Oral Oncol; 2011 Oct; 47(10):956-60. PubMed ID: 21880540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
    Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
    J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for oral precancer with noninvasive genetic cytology.
    Bremmer JF; Graveland AP; Brink A; Braakhuis BJ; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
    Cancer Prev Res (Phila); 2009 Feb; 2(2):128-33. PubMed ID: 19174582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-phase fraction and DNA ploidy in oral leukoplakia.
    Khanna R; Agarwal A; Khanna S; Basu S; Khanna AK
    ANZ J Surg; 2010; 80(7-8):548-51. PubMed ID: 20795971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microspectrophotometric determination of DNA in oral lesions.
    Giménez IB; Conti CJ
    J Oral Surg; 1977 Jun; 35(6):465-8. PubMed ID: 266061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma.
    Abou-Elhamd KE; Habib TN
    Oral Oncol; 2007 Apr; 43(4):366-72. PubMed ID: 16931118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of molecular markers to predict malignant potential of oral precancer.
    Warnakulasuriya S
    J Pathol; 2000 Mar; 190(4):407-9. PubMed ID: 10699986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.
    Thomas G; Tr S; George S P; Somanathan T; Sarojam S; Krishnankutti N; Sreedharan H; Ankathil R
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):309-316. PubMed ID: 32102504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.